Literature DB >> 27384357

The Expanded Programme on Immunisation in South Africa: A story yet to be told.

Nonhlanhla R Dlamini1, Popo Maja.   

Abstract

During the past two decades, immunisation has saved millions of lives and prevented countless illnesses and disabilities in South Africa(SA). However, vaccine-preventable diseases are still a threat. A vaccine-preventable disease that might lead to a 1- or 2-week illness in anadult, could prove deadly for infants, children or elderly people. Vaccination protects oneself and one's family. For example, adults are themost common source of pertussis (whooping cough) infection in infants, which can be deadly for the latter. This article demonstrates thecommitment of the SA government to immunisation, highlights key milestones of the Expanded Programme on Immunisation (EPI) anddispels the myth that the EPI in SA is in shambles.

Entities:  

Mesh:

Year:  2016        PMID: 27384357     DOI: 10.7196/SAMJ.2016.v106i7.10956

Source DB:  PubMed          Journal:  S Afr Med J


  4 in total

1.  Hepatitis B sero-prevalence in children under 15 years of age in South Africa using residual samples from community-based febrile rash surveillance.

Authors:  Nishi Prabdial-Sing; Lillian Makhathini; Sheilagh Brigitte Smit; Morubula Jack Manamela; Nkengafac Villyen Motaze; Cheryl Cohen; Melinda Shelley Suchard
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

2.  Prevalence and incidence rates of laboratory-confirmed hepatitis B infection in South Africa, 2015 to 2019.

Authors:  Shelina Moonsamy; Melinda Suchard; Pavitra Pillay; Nishi Prabdial-Sing
Journal:  BMC Public Health       Date:  2022-01-06       Impact factor: 3.295

Review 3.  Maternal vaccination: A narrative review.

Authors:  Sahra Ashkir; Olive P Khaliq; Mehreen Hunter; Jagidesa Moodley
Journal:  S Afr J Infect Dis       Date:  2022-09-26

4.  Co-detection of Bordetella pertussis and other respiratory organisms in children hospitalised with lower respiratory tract infection.

Authors:  Rudzani Muloiwa; Felix S Dube; Mark P Nicol; Gregory D Hussey; Heather J Zar
Journal:  Sci Rep       Date:  2020-10-02       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.